(Q40456169)

20 September 2017

title

Differential endostatin binding to bladder, prostate and kidney tumour vessels. (English)

1 reference

20 September 2017

1 reference

Annette Schmidt

1

1 reference

20 September 2017

Frank Sommer

2

1 reference

20 September 2017

Michael Reiner

3

1 reference

20 September 2017

Theodor Klotz

4

1 reference

20 September 2017

Udo Engelmann

5

1 reference

20 September 2017

Klaus Addicks

6

1 reference

20 September 2017

Wilhelm Bloch

7

1 reference

20 September 2017

publication date

1 January 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

95

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

174-179

1 reference

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05272.X

Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05272.X

Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05272.X

Influence of endostatin on embryonic vasculo- and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05272.X

Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05272.X

Genes expressed in human tumor endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05272.X

Combined effects of angiostatin and ionizing radiation in antitumour therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05272.X

Vascular endothelial growth factor is essential for corpus luteum angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05272.X

Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05272.X

Cell surface glypicans are low-affinity endostatin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05272.X

Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05272.X

Endostatin binds tropomyosin. A potential modulator of the antitumor activity of endostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05272.X

The Angiogenesis Inhibitor, Endostatin, Does Not Affect Murine Cutaneous Wound Healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05272.X

10.1111/J.1464-410X.2005.05272.X

21 January 2018

Identifiers

DOI

1 reference

release_7uzwljbrqbc6ve4ktvgdp3y4ey

20 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7uzwljbrqbc6ve4ktvgdp3y4ey

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference